Neurotransmitter Agents [Pharmacological Action]
Tree Number(s): D018377
MeSH Unique ID: D018377
- alanyl-prolyl-glycyl-tryptophanamide (Supplementary Concept)
- beta-Endorphin (MeSH Term)
- Bombesin (MeSH Term)
- Delta Sleep-Inducing Peptide (MeSH Term)
- Dynorphins (MeSH Term)
- Eledoisin (MeSH Term)
- Endorphins (MeSH Term)
- Enkephalin, Leucine (MeSH Term)
- Enkephalin, Methionine (MeSH Term)
- Enkephalins (MeSH Term)
- Nitric Oxide (MeSH Term)
- Physalaemin (MeSH Term)
- Substance P (MeSH Term)
- Kassinin (MeSH Term)
- Neurokinin B (MeSH Term)
- Neurokinin A (MeSH Term)
- Tachykinins (MeSH Term)
- alpha-Endorphin (MeSH Term)
- gamma-Endorphin (MeSH Term)
- Excitatory Amino Acids (MeSH Term)
- Opioid Peptides (MeSH Term)
- Enkephalin, Ala(2)-MePhe(4)-Gly(5)- (MeSH Term)
- Enkephalin, D-Penicillamine (2,5)- (MeSH Term)
- Pituitary Adenylate Cyclase-Activating Polypeptide (MeSH Term)
- tramiprosate (Supplementary Concept)
- brexanolone (Supplementary Concept)
- tetrahydropalmatine (Supplementary Concept)
- DSP 4 (Supplementary Concept)
- lidamidine (Supplementary Concept)
- dipivefrin (Supplementary Concept)
- ST 91 (Supplementary Concept)
- azepexole (Supplementary Concept)
- amidephrine (Supplementary Concept)
- anisodamine (Supplementary Concept)
- indanidine (Supplementary Concept)
- mivazerol (Supplementary Concept)
- adrafinil (Supplementary Concept)
- talipexole (Supplementary Concept)
- norfenefrine (Supplementary Concept)
- 2-cyclopentyl-4-phenylamino-1H-imidazo(4,5-c)quinoline (Supplementary Concept)
- deterenol (Supplementary Concept)
- 2-(4-bromo-2,5-dimethoxyphenyl)ethylamine (Supplementary Concept)
- cirazoline (Supplementary Concept)
- MH-76 compound (Supplementary Concept)
- apraclonidine (Supplementary Concept)
- 4-(1-(1-naphthyl)ethyl)imidazole (Supplementary Concept)
- romifidine (Supplementary Concept)
- lofexidine (Supplementary Concept)
- detomidine (Supplementary Concept)
- 3-nitrobiphenyline (Supplementary Concept)
- tizanidine (Supplementary Concept)
- amitraz (Supplementary Concept)
- dibromophakellin (Supplementary Concept)
- tulobuterol (Supplementary Concept)
- Ro 363 (Supplementary Concept)
- BRL 35135 (Supplementary Concept)
- zinterol (Supplementary Concept)
- ICI D7114 (Supplementary Concept)
- rimiterol (Supplementary Concept)
- amibegron (Supplementary Concept)
- arbutamine (Supplementary Concept)
- befunolol (Supplementary Concept)
- denopamine (Supplementary Concept)
- BRL 26830A (Supplementary Concept)
- CGP 12177 (Supplementary Concept)
- methoxyphenamine (Supplementary Concept)
- mabuterol (Supplementary Concept)
- bromoacetylalprenololmenthane (Supplementary Concept)
- broxaterol (Supplementary Concept)
- ractopamine (Supplementary Concept)
- reproterol (Supplementary Concept)
- dopexamine (Supplementary Concept)
- cimaterol (Supplementary Concept)
- BRL 37344 (Supplementary Concept)
- higenamine (Supplementary Concept)
- vanidipinedilol (Supplementary Concept)
- LAS190792 (Supplementary Concept)
- pirbuterol (Supplementary Concept)
- 3-(4-((6-((-2-hydroxy-2-(4-hydroxy-3-(hydroxymethyl)phenyl)ethyl)amino)hexyl)oxy)butyl)benzenesulfonamide (Supplementary Concept)
- vanidilol (Supplementary Concept)
- AZD-3199 (Supplementary Concept)
- bitolterol (Supplementary Concept)
- disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate (Supplementary Concept)
- solabegron (Supplementary Concept)
- 2-(2-chloro-4-(2-((2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)phenoxy)acetic acid (Supplementary Concept)
- ethyl 2-(2-chloro-4-(2-((2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)phenoxy)acetate (Supplementary Concept)
- ritobegron (Supplementary Concept)
- N-(4-(2-((2-hydroxy-2-(3-pyridinyl)ethyl)amino)ethyl)phenyl)-4-(4-(4-(trifluoromethyl)phenyl)thiazol-2-yl)benzenesulfonamide (Supplementary Concept)
- N-((4-((2-((2-hydroxy-2-(3-chlorophenyl)ethyl)amino)propyl)amino)phenyl)acetyl)-4-methylbenzenesulfonamide (Supplementary Concept)
- N-((3-((2-((2-hydroxy-2-(3-chlorophenyl)ethyl)amino)propyl)amino)phenyl)acetyl)-4-methylbenzenesulfonamide (Supplementary Concept)
- Amibegron hydrochloride (Supplementary Concept)
- 4'-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)ethyl)-3-methoxybiphenyl-4-carboxylic acid (Supplementary Concept)
- mirabegron (Supplementary Concept)
- ethyl 4-(4-((2-hydroxy-3-(4-hydroxy-3-((methylsulfonyl)amino)phenoxy)propyl)amino)cyclohexyl)benzoate (Supplementary Concept)
- 4'-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-2-(2-pyridyl)acetanilide (Supplementary Concept)
- 4'-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-2-(pyrimidin-2-yl)acetanilide (Supplementary Concept)
- 4'-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-2-(pyrazin-2-yl)acetanilide (Supplementary Concept)
- profenamine (Supplementary Concept)
- 1-(2-isopropoxyphenyl)-4-((2-oxopiperidin-1-yl)acetamido)propylpiperazine (Supplementary Concept)
- BE 2254 (Supplementary Concept)
- (2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane (Supplementary Concept)
- ifenprodil (Supplementary Concept)
- EEDQ (Supplementary Concept)
- 1-benzylimidazole (Supplementary Concept)
- BRL 44408 (Supplementary Concept)
- naftopidil (Supplementary Concept)
- dapiprazole (Supplementary Concept)
- nipradilol (Supplementary Concept)
- medroxalol (Supplementary Concept)
- 1-(2-pyrimidinyl)piperazine (Supplementary Concept)
- benalfocin (Supplementary Concept)
- chlorethylclonidine (Supplementary Concept)
- BMY 7378 (Supplementary Concept)
- midaglizole (Supplementary Concept)
- amosulalol (Supplementary Concept)
- AR-C239 (Supplementary Concept)
- SNAP 6201 (Supplementary Concept)
- 5-carboxamido-1-(N-(3-(4-cyano-4-phenylpiperidin-1-yl)propyl)carboxamido)-6-(2,4-difluorophenyl)-4-ethyl-2-oxo-1,2,3,6-tetrahydropyrimidine (Supplementary Concept)
- 1-(N-(3-(4-methyl-4-phenylpiperidin-1-yl)propyl)carboxamido)-6-(3,4-difluorophenyl)-5-methoxycarbonyl-4-methoxymethyl-2-oxo-1,2,3,6-tetrahydropyrimidine (Supplementary Concept)
- bevantolol (Supplementary Concept)
- 1,2,3,6-tetrahydro-1-(N-((4-(2-nitrophenyl)piperazin-1-yl)propyl)carboxamido)-4-methyl-6-(3,4-difluorophenyl)-2-oxopyrimidine (Supplementary Concept)
- benextramine (Supplementary Concept)
- phenylpiperazine (Supplementary Concept)
- 3-(4-(1-(4-fluorophenyl)-5-(1-methyl-1,2,4-triazol-3-yl)-1H-indol-3-yl)-1-piperidinyl)propionitrile (Supplementary Concept)
- arotinolol (Supplementary Concept)
- SK and F 104078 (Supplementary Concept)
- YM 12617 (Supplementary Concept)
- 2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone (Supplementary Concept)
- efaroxan (Supplementary Concept)
- L 657743 (Supplementary Concept)
- 5-methylurapidil (Supplementary Concept)
- 2-methoxyidazoxan (Supplementary Concept)
- proroxan (Supplementary Concept)
- 7,8-(methylenedioxy)-14-hydroxyberbane (Supplementary Concept)
- benoxathian (Supplementary Concept)
- monatepil (Supplementary Concept)
- 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one (Supplementary Concept)
- urapidil (Supplementary Concept)
- bunazosin (Supplementary Concept)
- ethyl 4-(3-(4-(2-methoxyphenyl)piperazinyl)propyl)aminoquinazolin-2-carboxylate (Supplementary Concept)
- JTH 601 (Supplementary Concept)
- Terazosin (Supplementary Concept)
- RS 100329 (Supplementary Concept)
- S 18327 (Supplementary Concept)
- 4-(2-(2-methoxyphenoxy)ethylaminomethyl)-2,2-diphenyl(1,3)dioxolane (Supplementary Concept)
- 4-(2-phenoxyethylaminomethyl)-2,2-diphenyl(1,3)dioxolane (Supplementary Concept)
- 2-(2-(n-4-o-methoxyphenyl-N-1-piperazinyl)ethyl)-1-tetralone (Supplementary Concept)
- 4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-(4-(morpholinocarbonyl)--perhydro-1,4-diazepin-1-yl)quinoline (Supplementary Concept)
- bucindolol (Supplementary Concept)
- trimazosin (Supplementary Concept)
- silodosin (Supplementary Concept)
- alfuzosin (Supplementary Concept)
- L 771688 (Supplementary Concept)
- 6-(1-benzimidazolyl)-2-((4-(2-methoxyphenyl)piperazin-1-yl)butyl)pyridazin-3(2H)-one (Supplementary Concept)
- 6-(imidazolyl)-2-((4-(2-chlorophenyl)piperazin-1-yl)heptyl)pyridazin-3(2H)-one (Supplementary Concept)
- 6-(1-indolyl)-2-((4-(2-methoxyphenyl)piperazin-1-yl)butyl)pyridazin-3(2H)-one (Supplementary Concept)
- 2-(3-(4-(2-isopropoxyphenyl)piperazin-1-yl)propyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione (Supplementary Concept)
- N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexane carboxamide (Supplementary Concept)
- 2-(3-fluorophenyl)-2,3-dihydro-N-(2-hydroxy-3-(4-(2-(1-methylethoxy)phenyl)-1-piperazinyl)propyl)-1,3-dioxo-1H-isoindole-5-carboxamide (Supplementary Concept)
- 2-(4-methylphenyll)-2,3-dihydro-N-(2-hydroxy-3-(4-(2-(1-methylethoxy)phenyl)-1-piperazinyl)propyl)-1,3-dioxo-1H-isoindole-5-carboxamide (Supplementary Concept)
- 8-((4-(2,5-dichlorophenyl)-1-piperazinyl)ethyl)-8-azaspiro(4,5)decane-7,9-dione (Supplementary Concept)
- 8-(2-(4-(2,5-dichlorophenyl)-1-piperazinyl)ethyl)-8-azaspiro(4,5)dec-9,10-en-7-one (Supplementary Concept)
- 8-(2-(4-(2,4,5-trifluorophenyl)piperazin-1-yl)ethyl)-8-azaspiro(4.5)decane-7,9-dione (Supplementary Concept)
- 8-(2-(4-(2,4,5-trifluorophenyl)piperazin-1-yl)-1-methylethyl)-8-azaspiro(4.5)decane-7,9-dione (Supplementary Concept)
- CP 93393 (Supplementary Concept)
- 1-((imidazolidin-2-yl)imino)indazole (Supplementary Concept)
- 1-((imidazolidin-2-yl)imino)-7-methylindazole (Supplementary Concept)
- cyclazosin (Supplementary Concept)
- atipamezole (Supplementary Concept)
- N-(2-(4-(2,3-dihydrobenzo(1,4)dioxin-2-ylmethyl)-(1,4)diazepan-2-yl)ethyl)-2-phenoxynicotinamide (Supplementary Concept)
- bufuralol (Supplementary Concept)
- talinolol (Supplementary Concept)
- indenolol (Supplementary Concept)
- bopindolol (Supplementary Concept)
- bufetolol (Supplementary Concept)
- landiolol (Supplementary Concept)
- tilisolol (Supplementary Concept)
- butofilolol (Supplementary Concept)
- 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (Supplementary Concept)
- epanolol (Supplementary Concept)
- ICI 89406 (Supplementary Concept)
- tobanum (Supplementary Concept)
- ICI 118551 (Supplementary Concept)
- 3-iodopindolol (Supplementary Concept)
- prizidilol (Supplementary Concept)
- tertatolol (Supplementary Concept)
- 5-hydroxypropafenone (Supplementary Concept)
- cyanopindolol (Supplementary Concept)
- carazolol (Supplementary Concept)
- IPS 339 (Supplementary Concept)
- mepindolol (Supplementary Concept)
- flestolol (Supplementary Concept)
- exaprolol (Supplementary Concept)
- CGP 20712A (Supplementary Concept)
- esmolol (Supplementary Concept)
- 4-(2-hydroxy-3-isopropylaminopropoxy)-7-amino-6-iodofluorenone (Supplementary Concept)
- 3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate (Supplementary Concept)
- L 750355 (Supplementary Concept)
- 2,3-dihydrothiopyrano(2,3-b)pyridine (Supplementary Concept)
- 3,4-methylenedioxyethamphetamine (Supplementary Concept)
- ethylphenidate (Supplementary Concept)
- dibutylone (Supplementary Concept)
- virodhamine (Supplementary Concept)
- 1-pentyfluoro-1H-indole-3-carboxylic acid 8-quinolinyl ester (Supplementary Concept)
- anandamide (Supplementary Concept)
- palmidrol (Supplementary Concept)
- N-oleoylethanolamine (Supplementary Concept)
- 5F-APP-PICA (Supplementary Concept)
- HU 308 (Supplementary Concept)
- JHW 015 (Supplementary Concept)
- naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (Supplementary Concept)
- 3-(5-dimethylcarbamoylpent-1-enyl)-N-(2-hydroxy-1-methylethyl)benzamide (Supplementary Concept)
- lenabasum (Supplementary Concept)
- arachidonoyl-2 chloroethanolamine (Supplementary Concept)
- JWH-073 (Supplementary Concept)
- AM 694 (Supplementary Concept)
- (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone (Supplementary Concept)
- 3-(2-nitro-1-phenylethyl)-2-phenyl-1H-indole (Supplementary Concept)
- CB65 (Supplementary Concept)
- iodopravadoline (Supplementary Concept)
- glyceryl 2-arachidonate (Supplementary Concept)
- 1-(4-chlorobutyl)-1,2-dihydro-N-(4-methylcyclohexyl)-2-oxo-1,8-naphthyridine-3-carboxamide (Supplementary Concept)
- AM9405 (Supplementary Concept)
- EG-018 (Supplementary Concept)
- CB2 receptor agonist LY2828360 (Supplementary Concept)
- N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide (Supplementary Concept)
- cannabinoid receptor agonist 13 (Supplementary Concept)
- THJ-2201 (Supplementary Concept)
- methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamide)-3,3-dimethylbutanoate (Supplementary Concept)
- LY 320135 (Supplementary Concept)
- ibipinabant (Supplementary Concept)
- surinabant (Supplementary Concept)
- 192 IgG-saporin (Supplementary Concept)
- bromantane (Supplementary Concept)
- imidacloprid (Supplementary Concept)
- subecholine (Supplementary Concept)
- rimabotulinumtoxinB (Supplementary Concept)
- botulinum toxin type D (Supplementary Concept)
- abobotulinumtoxinA (Supplementary Concept)
- incobotulinumtoxinA (Supplementary Concept)
- furtrethonium (Supplementary Concept)
- xanomeline (Supplementary Concept)
- oxotremorine M (Supplementary Concept)
- (S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one (Supplementary Concept)
- ethyl 3-(4-(6-fluoro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl)pyrrolidine-1-carboxylate (Supplementary Concept)
- CS 932 (Supplementary Concept)
- 6-(4-butylthio-1,2,5-thiadiazol-3-yl)-1-azabicyclo(3.2.1)octane (Supplementary Concept)
- cevimeline (Supplementary Concept)
- TAK-071 (Supplementary Concept)
- 3-(2,4-dimethoxybenzylidene)anabaseine (Supplementary Concept)
- epibatidine (Supplementary Concept)
- 3'-(5-chlorothiophen-2-yl)spiro-1-azabicyclo(2.2.2)octane-3,5'-(1',3')-oxazolidin-2'-one (Supplementary Concept)
- N-(3-fluorobenzyl)-N-methylethanolamine (Supplementary Concept)
- Donnatal (Supplementary Concept)
- chlordiazepoxide, clidinium drug combination (Supplementary Concept)
- triethylcholine (Supplementary Concept)
- tofenacin (Supplementary Concept)
- azatadine (Supplementary Concept)
- desloratadine (Supplementary Concept)
- phenglutarimide (Supplementary Concept)
- glycopyrronium tosylate (Supplementary Concept)
- temiverine (Supplementary Concept)
- propiverine (Supplementary Concept)
- trospium chloride (Supplementary Concept)
- chlorphenoxamine (Supplementary Concept)
- octotropine methylbromide (Supplementary Concept)
- darifenacin (Supplementary Concept)
- bornaprine (Supplementary Concept)
- biperiden lactate (Supplementary Concept)
- 4-diphenylacetoxy-1,1-dimethylpiperidinium (Supplementary Concept)
- fesoterodine (Supplementary Concept)
- diisopropyl(2-(3-(1-pyridin-2-ylethyl)-1H-inden-2-yl)ethyl)amine (Supplementary Concept)
- caproctamine (Supplementary Concept)
- 6-(ethyl-(2-methoxybenzyl)amino)hexanoic acid (8-((6-(ethyl-(2-methoxybenzyl)amino)hexanoyl)methylamino)octyl)methylamide (Supplementary Concept)
- 8-benzyloxymethyl-3-ethoxycarbonyl-4-hydroxy-1-azabicyclo(3.3.1)non-3-ene (Supplementary Concept)
- oxybutynin (Supplementary Concept)
- octylonium (Supplementary Concept)
- fencarbamide (Supplementary Concept)
- emepronium carrageenate (Supplementary Concept)
- hexahydrosiladifenidol (Supplementary Concept)
- 1-((3,4-methylenedioxyphenyl)sulfonylphenyl)-1-(1-(1-(n-propylsulfonyl)morpholin-4-yl)morpholin-4-yl)dioxole (Supplementary Concept)
- 1-((4-methoxyphenyl)sulfonylphenyl)-1(1-(1-(1-naphthylcarbonyl)morpholin-4-yl)morpholin-4-yl)dioxole (Supplementary Concept)
- 1-((4-methoxyphenyl)sulfonylphenyl)-1-(1-(1-(4-fluoro-1-naphthylcarbonyl)morpholin-4-yl)morpholin-4-yl)dioxole (Supplementary Concept)
- lithocholylcholine (Supplementary Concept)
- 4-fluorohexahydrosiladifenidol (Supplementary Concept)
- DA-8010 (Supplementary Concept)
- delta-philanthotoxin (Supplementary Concept)
- 1-hexanol (Supplementary Concept)
- 3-(trifluoromethyl)-3-(3-iodophenyl)diazirine (Supplementary Concept)
- alphaA-conotoxin OIVB, Conus obscurus (Supplementary Concept)
- 4-((2-(1-methyl-2-pyrrolidinyl)ethyl)thio)phenol hydrochloride (Supplementary Concept)
- N-n-decylnicotinium (Supplementary Concept)
- 4-((3-trifluoromethyl)-3H-diazirin-3-yl)benzoylcholine (Supplementary Concept)
- hexafluorenium (Supplementary Concept)
- alpha-conotoxin MII (Supplementary Concept)
- methyllycaconitine (Supplementary Concept)
- acantoxin IVa, Acanthophis (Supplementary Concept)
- 4-(6-heptenyl)-8-methylindolizidine (Supplementary Concept)
- 4-allyl-8-ethylquinolizidine (Supplementary Concept)
- 1,2,2a,5,5a,6,7,8,8a-nonahydro-4,6,8-trimethylquinolizino(1,8-ae)pyrrole (Supplementary Concept)
- 2,2,6,6-tetramethylpiperidin-4-yl heptanoate (Supplementary Concept)
- triethyl-(beta-4-stilbenoxyethyl)ammonium (Supplementary Concept)
- MB408 (Supplementary Concept)
- MB442 (Supplementary Concept)
- MB444 (Supplementary Concept)
- 2,5-hexanedione (Supplementary Concept)
- normeperidine (Supplementary Concept)
- phosalone (Supplementary Concept)
- phoxim (Supplementary Concept)
- demecarium (Supplementary Concept)
- distigmine (Supplementary Concept)
- 2-chloro-12-(2-piperidinoethyl)dibenzo(d,g)-1,3,6-dioxazocine (Supplementary Concept)
- physostigmine heptyl (Supplementary Concept)
- 1,10-phenanthroline (Supplementary Concept)
- O,O'-(3-methyl)phenylenediphorylchloride (Supplementary Concept)
- N,N'-(3-methyl)phenylenediaminophosphorylchloridate (Supplementary Concept)
- (9-amino-5,6,7,8-tetrahydroacridin-4-yl)methanol (Supplementary Concept)
- TZ2PA6 compound (Supplementary Concept)
- Z 338 (Supplementary Concept)
- AP 2238 (Supplementary Concept)
- 14-norhuperzine A (Supplementary Concept)
- velnacrine (Supplementary Concept)
- methanesulfonyl fluoride (Supplementary Concept)
- alternariol (Supplementary Concept)
- N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine (Supplementary Concept)
- fasciculin (Supplementary Concept)
- phenserine (Supplementary Concept)
- octamethyl pyrophosphoramide (Supplementary Concept)
- 3-hydroxy-2-oxoindole (Supplementary Concept)
- tabun (Supplementary Concept)
- VX (Supplementary Concept)
- huperzine A (Supplementary Concept)
- 6,10,14-trimethylpentadeca-5,10-dien-2,12-dione (Supplementary Concept)
- ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzo(1,8)naphthyridine-3-carboxylate (Supplementary Concept)
- 6-(ethyl-(2-methoxybenzyl)amino)-1-(1'-(6-(ethyl-(2-methoxybenzyl)amino)hexanoyl)-(4,4')bipiperidinyl-1-yl)hexan-1-one (Supplementary Concept)
- bis(18)-huperzine B (Supplementary Concept)
- isosarcodine (Supplementary Concept)
- N-(3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl)-N'-(4-(1,2,3,4-tetrahydroacridin-9-ylsulfanyl)butyl)acetamide (Supplementary Concept)
- 3-methyl-2-(4-methyl-1-piperazinyl)-N-(7-((1,2,3,4-tetrahydroacridin-9-yl)amino)heptyl)quinoline-4-carboxamide (Supplementary Concept)
- asoxime chloride (Supplementary Concept)
- diacetylmonoxime (Supplementary Concept)
- N,N'-monomethylenebis(pyridiniumaldoxime) (Supplementary Concept)
- HLo 7 (Supplementary Concept)
- pralidoxime (Supplementary Concept)
- benserazide, levodopa drug combination (Supplementary Concept)
- BAK4-54 (Supplementary Concept)
- CAB2-015 (Supplementary Concept)
- CE-123 (Supplementary Concept)
- stepholidine (Supplementary Concept)
- brexpiprazole (Supplementary Concept)
- N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride (Supplementary Concept)
- fananserin (Supplementary Concept)
- SK and F 82958 (Supplementary Concept)
- alnespirone (Supplementary Concept)
- NCQ 298 (Supplementary Concept)
- A 68930 (Supplementary Concept)
- ergocryptine (Supplementary Concept)
- A 77636 (Supplementary Concept)
- PD 158771 (Supplementary Concept)
- dironyl (Supplementary Concept)
- 3-N-methylspiperone (Supplementary Concept)
- 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine (Supplementary Concept)
- docarpamine (Supplementary Concept)
- 2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin (Supplementary Concept)
- naxagolide (Supplementary Concept)
- preclamol (Supplementary Concept)
- BP 897 (Supplementary Concept)
- 7-hydroxy-2-N,N-dipropylaminotetralin (Supplementary Concept)
- mesulergine (Supplementary Concept)
- ibopamine (Supplementary Concept)
- 1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine (Supplementary Concept)
- dihydrexidine (Supplementary Concept)
- 3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol (Supplementary Concept)
- 3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine (Supplementary Concept)
- ropinirole (Supplementary Concept)
- quinagolide (Supplementary Concept)
- rotigotine (Supplementary Concept)
- quinelorane (Supplementary Concept)
- CY 208-243 (Supplementary Concept)
- N-(2-chloro-6-methylergoline-8-yl)-2,2-dimethylpropanamide (Supplementary Concept)
- roxindole (Supplementary Concept)
- N-n-propylnorapomorphine (Supplementary Concept)
- carbidopa, levodopa drug combination (Supplementary Concept)
- N-((4-(2-cyanophenyl)piperazinyl)methyl)benzamide (Supplementary Concept)
- 2-(4-(2-cyanophenyl)-1-piperazinyl)-N-(3-methylphenyl) acetamide (Supplementary Concept)
- SK and F 81297 (Supplementary Concept)
- SK and F 77434 (Supplementary Concept)
- PF-06669571 (Supplementary Concept)
- ADTN (Supplementary Concept)
- (3,4-dihydroxyphenylamino)-2-imidazoline (Supplementary Concept)
- spiroxatrine (Supplementary Concept)
- aceprometazine (Supplementary Concept)
- FLB 457 (Supplementary Concept)
- 1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline (Supplementary Concept)
- (5,6-dimethoxyindan-2-yl)dipropylamine (Supplementary Concept)
- CP 293019 (Supplementary Concept)
- VK4-116 (Supplementary Concept)
- 7-methyl-2,3-dimethoxy-5,6,7,8,9,14-hexahydrodibenz(d,g)azecine (Supplementary Concept)
- 4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone (Supplementary Concept)
- 7-methyl-6,7,8,9,14,15-hexahydro-5H-benz(d)indolo(2,3-g)azecine (Supplementary Concept)
- nemonapride (Supplementary Concept)
- 3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-benzazepine (Supplementary Concept)
- 3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide (Supplementary Concept)
- 1H-3-benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl- (Supplementary Concept)
- UH 232 (Supplementary Concept)
- eticlopride (Supplementary Concept)
- N-(2-((bis(4-fluorophenyl)methyl)thio)ethyl)-3-phenylpropan-1-amine (Supplementary Concept)
- S-phenylpiracetam (Supplementary Concept)
- bromopride (Supplementary Concept)
- ziprasidone (Supplementary Concept)
- nafadotride (Supplementary Concept)
- flupenthixol decanoate (Supplementary Concept)
- CI 1030 (Supplementary Concept)
- FAUC 346 (Supplementary Concept)
- FAUC 365 (Supplementary Concept)
- ecopipam (Supplementary Concept)
- 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (Supplementary Concept)
- 8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol (Supplementary Concept)
- 1-methyl-1,2,3,4-tetrahydroisoquinoline (Supplementary Concept)
- 5-methoxy-1-methyl-2-(n-propylamino)tetralin (Supplementary Concept)
- mesdopetam (Supplementary Concept)
- 3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole (Supplementary Concept)
- GR 103691 (Supplementary Concept)
- 1-(2-ethoxyphenyl)-4-(3-(3-thiophen-2-ylisoxazolin-5-yl)propyl)piperazine (Supplementary Concept)
- S 18126 (Supplementary Concept)
- NGB 2849 (Supplementary Concept)
- 3-(4-(4-chlorophenyl)piperazinylmethyl)pyrazolo(1,5-a)pyridine (Supplementary Concept)
- mazapertine succinate (Supplementary Concept)
- 1-methyl-3-(2-(4-phenylbutyl)phenoxymethyl)piperidine (Supplementary Concept)
- 1-ethyl-3-(2-(4-(3-methoxyphenyl)butyl)phenoxymethyl)piperidine (Supplementary Concept)
- 1-methyl-3-(2-(4-(3-methoxyphenyl)butyl)phenoxymethyl)piperidine (Supplementary Concept)
- 8-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piperazin-1-yl)-4H-benzo(1,4)oxazin-2-methyl-3-one (Supplementary Concept)
- 2-((benzyl)propylamino)-5-methoxytetralin (Supplementary Concept)
- 9-(4-methylpiperazin-1-yl)pyrrolo(2,1-b)benzothiazepine (Supplementary Concept)
- 1H-indole-2-carboxylic acid (4-(2-(cyano-3,4-dihydro-1H-isoquinolin-2-yl)ethyl)cyclohexyl)amide (Supplementary Concept)
- fallypride (Supplementary Concept)
- N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine (Supplementary Concept)
- CLR151 (Supplementary Concept)
- 1-((2-phenylcyclopropyl)methyl)-4-(2,4-dichlorophenyl)piperazine (Supplementary Concept)
- 1-((2-phenylcyclopropyl)-methyl)-4-(2,4-dimethylphenyl)piperazine (Supplementary Concept)
- 2-amino-2,3,3a,4,5,6-hexahydro-1H-phenalene (Supplementary Concept)
- 5-bromo-N-(1-ethyl-4-methylhexahydro-1H-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridinecarboxamide 2-fumarate (Supplementary Concept)
- N-((2,2-dimethyl-2,3-dihydrobenzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)benzylamine (Supplementary Concept)
- YKP 1358 (Supplementary Concept)
- 3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine (Supplementary Concept)
- 1-((5-methoxy-1H-indol-3-yl)methyl)-4-(4-(methylthio)phenyl)piperidin-4-ol (Supplementary Concept)
- (1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester (Supplementary Concept)
- vanoxerine (Supplementary Concept)
- 1-(2 (diphenylmethoxy)ethyl)-4-(3-phenylpropyl)piperazine (Supplementary Concept)
- cocaethylene (Supplementary Concept)
- avermectin (Supplementary Concept)
- (alpha-carboxycyclopropyl)glycine (Supplementary Concept)
- 3,5-dihydroxyphenylglycine (Supplementary Concept)
- UBP684 (Supplementary Concept)
- UBP753 (Supplementary Concept)
- 2-amino-4-phosphonobutyric acid (Supplementary Concept)
- 1-hydroxy-3-amino-2-pyrrolidone (Supplementary Concept)
- beta-N-methylamino-L-alanine (Supplementary Concept)
- LSP2-9166 (Supplementary Concept)
- eglumetad (Supplementary Concept)
- 2-chloro-5-hydroxyphenylglycine (Supplementary Concept)
- 2-amino-3-(3-(carboxymethoxy)-5-tert-butyl-4-isoxazolyl)propionic acid (Supplementary Concept)
- 2-amino-4-carboxy-7-(2-naphthyl)hept-6-enoic acid (Supplementary Concept)
- 2-amino-3-phosphonopropionic acid (Supplementary Concept)
- 2-amino-3-((3,4-difluorophenyl)sulfanylmethyl)-4-hydroxy-bicyclo(3.1.0)hexane-2,6-dicarboxylic acid hydrochloride (Supplementary Concept)
- conantokin-T (Supplementary Concept)
- CGP 39653 (Supplementary Concept)
- gacyclidine (Supplementary Concept)
- 4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline (Supplementary Concept)
- 2-amino-4-methyl-5-phosphono-3-pentenoic acid (Supplementary Concept)
- CGP 39551 (Supplementary Concept)
- SDZ EAA 494 (Supplementary Concept)
- 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione (Supplementary Concept)
- LY 235959 (Supplementary Concept)
- selfotel (Supplementary Concept)
- 6-methyl-2-(phenylethynyl)pyridine (Supplementary Concept)
- 2,3-piperidinedicarboxylic acid (Supplementary Concept)
- 2-amino-7-phosphonoheptanoic acid (Supplementary Concept)
- conotoxin GV (Supplementary Concept)
- FG 9041 (Supplementary Concept)
- NPC 12626 (Supplementary Concept)
- GYKI 52466 (Supplementary Concept)
- HU 211 (Supplementary Concept)
- 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline (Supplementary Concept)
- GYKI 53655 (Supplementary Concept)
- 4-carboxyphenylglycine (Supplementary Concept)
- alpha-methyl-4-carboxyphenylglycine (Supplementary Concept)
- aptiganel (Supplementary Concept)
- licostinel (Supplementary Concept)
- L 701324 (Supplementary Concept)
- 1-aminoindan-1,5-dicarboxylic acid (Supplementary Concept)
- kaitocephalin (Supplementary Concept)
- 7-chlorokynurenic acid (Supplementary Concept)
- eliprodil (Supplementary Concept)
- carbinoxamine, dextromethorphan, pseudoephedrine drug combination (Supplementary Concept)
- 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (Supplementary Concept)
- caroverine (Supplementary Concept)
- 2-Oxo-PCE (Supplementary Concept)
- phetharbital (Supplementary Concept)
- 2-(1,1-dimethyl-1,3-dihydro-benzo(e)indol-2-ylidene)-malonaldehyde (Supplementary Concept)
- BCI-838 (Supplementary Concept)
- 3-(2-((phenylamino)carbonyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid (Supplementary Concept)
- LY 341495 (Supplementary Concept)
- 5,7-dichlorokynurenic acid (Supplementary Concept)
- glutamic acid diethyl ester (Supplementary Concept)
- ketobemidone (Supplementary Concept)
- phenazepam (Supplementary Concept)
- N-(4,4-diphenyl-3-butenyl)nipecotic acid (Supplementary Concept)
- gaboxadol (Supplementary Concept)
- progabide (Supplementary Concept)
- 2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one (Supplementary Concept)
- ethyl 6-benzyloxy-beta-carboline-3-carboyxlate (Supplementary Concept)
- piperidine-4-sulfonic acid (Supplementary Concept)
- adipiplon (Supplementary Concept)
- 3-aminopropylphosphinic acid (Supplementary Concept)
- isoguvacine (Supplementary Concept)
- 4-amino-3-phenylbutyric acid (Supplementary Concept)
- 6,6-dimethyl-3-(2-hydroxyethyl)thio-1-(thiazol-2-yl)-6,7-dihydro-2-benzothiophen-4(5H)-one (Supplementary Concept)
- NNC 14-0185 (Supplementary Concept)
- NNC 14-0189 (Supplementary Concept)
- 3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl) 7-bromo-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5.alpha)-benzodiazepine (Supplementary Concept)
- 9-chloro-7-(2-chlorophenyl)-5H-pyrimido(5,4-d)(2)benzazepine (Supplementary Concept)
- 1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one (Supplementary Concept)
- 3-amino-2-fluoropropylsulfinic acid (Supplementary Concept)
- N,N-dimethyl-(2-(4-methylphenyl)-5-methylpyrazolo(1,5-a)pyrimidin-3-yl)acetamide (Supplementary Concept)
- L 838,417 (Supplementary Concept)
- 6,3'-dibromoflavone (Supplementary Concept)
- 6-nitro-3'-bromoflavone (Supplementary Concept)
- 3'-(5-(1-hydroxy-1-methylethyl)benzoimidazol-1-yl)biphenyl-2-carbonitrile (Supplementary Concept)
- 3-phenyl-6-(2-pyridyl)methoxy-7,8,9,10-tetrahydro(7,10-ethano)-1,2,4-triazolo(3,4-a)phthalazine (Supplementary Concept)
- N-(3-fluoro-4-(2-(propylamino)ethoxy)phenyl)-4,5,6,7-tetrahydro-4-oxo-1H-indole-3-carboxamide (Supplementary Concept)
- deschloroetizolam (Supplementary Concept)
- abp-700 (Supplementary Concept)
- N-(p-methylbenzyl)-5-nitroindol-3-ylglyoxylamide (Supplementary Concept)
- 7-chloro-5((cis-3,5-dimethylpiperazine)carbonyl)imidazo(1,5a)quinoline-3-carboxylate (Supplementary Concept)
- lesogaberan (Supplementary Concept)
- 7-cyclobutyl-6-(2-methyl-2H-1,2,4-triazol-3-ylmethoxy)-3-phenyl-1,2,4-triazolo(4,3-b)pyridazine (Supplementary Concept)
- 2-methoxy-3,8,9-trihydroxy coumestan (Supplementary Concept)
- 9-chloro-2-phenyl-(1,2,3)triazolo(1,2-a)(1,2,4)benzotriazin-1,5(6H)-dione (Supplementary Concept)
- 3-amino-2-(S)-hydroxypropyl-methyl-phosphinic acid (Supplementary Concept)
- 2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol (Supplementary Concept)
- CGP 13501 (Supplementary Concept)
- arbaclofen placarbil (Supplementary Concept)
- FG 7142 (Supplementary Concept)
- CGP 55845A (Supplementary Concept)
- NNC 711 (Supplementary Concept)
- (3-aminopropyl)(n-butyl)phosphinic acid (Supplementary Concept)
- bicuculline methochloride (Supplementary Concept)
- phaclofen (Supplementary Concept)
- RU 5135 (Supplementary Concept)
- ZK 93426 (Supplementary Concept)
- KN 244 (Supplementary Concept)
- saclofen (Supplementary Concept)
- gabazine (Supplementary Concept)
- CGP 35348 (Supplementary Concept)
- 5-hydroxysaclofen (Supplementary Concept)
- 1,3-bis(8-ethynyl-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxy)propyl diester (Supplementary Concept)
- picrotoxinin (Supplementary Concept)
- S44819 (Supplementary Concept)
- fipronil sulfone (Supplementary Concept)
- 17-phenylandrost-16-en-3-ol (Supplementary Concept)
- 6-bromo-3'-nitroflavone (Supplementary Concept)
- 3-aminopropyl-P-(alpha-hydroxybenzyl)phosphinic acid (Supplementary Concept)
- 3-aminopropyl-(1,1,-difluoro-n-butyl)phosphinic acid (Supplementary Concept)
- CGP 47332A (Supplementary Concept)
- 2-hydroxysaclofen (Supplementary Concept)
- 3-amino-2-hydroxypropylcyclohexylmethylphosphinic acid (Supplementary Concept)
- CGP 71872 (Supplementary Concept)
- 2-hydroxy-2-(4'-chlorophenyl)butyramide (Supplementary Concept)
- 3-hydroxy-3-(4'-chlorophenyl)pentanamide (Supplementary Concept)
- 4-hydroxy-4-(4'-chlorophenyl)hexanamide (Supplementary Concept)
- SGE-872 (Supplementary Concept)
- nimetazepam (Supplementary Concept)
- zaleplon (Supplementary Concept)
- imidazenil (Supplementary Concept)
- indiplon (Supplementary Concept)
- PF-06372865 (Supplementary Concept)
- ganaxolone (Supplementary Concept)
- amobarbital, secobarital drug combination (Supplementary Concept)
- ASP8062 (Supplementary Concept)
- SGE-102 (Supplementary Concept)
- pyrazolam (Supplementary Concept)
- CI 966 (Supplementary Concept)
- histamine phosphate (Supplementary Concept)
- alpha-methylhistamine (Supplementary Concept)
- imetit (Supplementary Concept)
- 2-(2-aminoethyl)pyridine (Supplementary Concept)
- 2-(2-(3-(3-fluorophenyl)-3-phenylpropyl)-1H-imidazol-4-yl)ethanamine (Supplementary Concept)
- 2-(2-aminoethyl)thiazole (Supplementary Concept)
- 2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane (Supplementary Concept)
- SK and F 91488 (Supplementary Concept)
- 4-(imidazol-4-ylmethyl)-1-methylpiperidine (Supplementary Concept)
- 4-(4-methyl-3-pyrrolidinyl)-1H-imidazole dihydrochloride (Supplementary Concept)
- traxanox (Supplementary Concept)
- bamipine (Supplementary Concept)
- suplatast tosilate (Supplementary Concept)
- ozagrel (Supplementary Concept)
- thonzylamine (Supplementary Concept)
- AQ 0145 (Supplementary Concept)
- nitrophorin (Supplementary Concept)
- toreforant (Supplementary Concept)
- (2-(2-(2-methylpyrrolidin-1-yl)ethyl)benzofuran-5-yl)(5-nitropyridin-2-yl)amine (Supplementary Concept)
- GR 190028 (Supplementary Concept)
- FUB 271 (Supplementary Concept)
- N-(4-chlorobenzyl)-N-(7-pyrrolidin-1-ylheptyl)guanidine (Supplementary Concept)
- N-(4-chlorobenzyl)-N-(6-pyrrolidin-1-ylhexyl)guanidine (Supplementary Concept)
- imoproxifan (Supplementary Concept)
- 4-((3-(4-(2-aminopropanoyl)-1-piperazinyl)propoxy)phenyl)cyclopropylmethanone (Supplementary Concept)
- SCH 79687 (Supplementary Concept)
- 1-(4-(3-piperidin-1-ylpropoxy)benzyl)piperidine (Supplementary Concept)
- pemirolast (Supplementary Concept)
- tesmilifene (Supplementary Concept)
- repirinast (Supplementary Concept)
- quifenadine (Supplementary Concept)
- 4-(1-cyclohexylpentanoyl-4-piperidyl)-1H-imidazole (Supplementary Concept)
- isothipendyl (Supplementary Concept)
- buclizine (Supplementary Concept)
- proxyfan (Supplementary Concept)
- 3-(1H-imidazol-4-yl)propyl N-(1,2,2-trimethylpropyl) carbamate (Supplementary Concept)
- brompheniramine maleate, pseudoephedrine sulfate drug combination (Supplementary Concept)
- benzonitrile, 4-(2-(2-((2r)-2-methyl-1-pyrrolidinyl)ethyl)-5-benzofuranyl)- (Supplementary Concept)
- 4-(6-cyclohexylhex-3-enyl)imidazole (Supplementary Concept)
- 4-(2-(5,5-dimethylhex-1-ynyl)cyclopropyl)imidazole (Supplementary Concept)
- 4-(piperazin-1-yl)-8-(trifluoromethyl)pyrido(2,3-e)(1,2,4) triazolo(4,3-a)pyrazine (Supplementary Concept)
- tritoqualine (Supplementary Concept)
- dexchlorpheniramine (Supplementary Concept)
- proxicromil (Supplementary Concept)
- doxylamine succinate (Supplementary Concept)
- fonazine (Supplementary Concept)
- dibenzheptropine (Supplementary Concept)
- embramine (Supplementary Concept)
- mequitazine (Supplementary Concept)
- pseudoephedrine, triprolidine drug combination (Supplementary Concept)
- NCO 650 (Supplementary Concept)
- epinastine (Supplementary Concept)
- azatadine maleate, pseudoephedrine sulfate drug combination (Supplementary Concept)
- isospaglumic acid (Supplementary Concept)
- trimeprazine tartrate (Supplementary Concept)
- histabudifen (Supplementary Concept)
- histapendifen (Supplementary Concept)
- lodoxamide tromethamine (Supplementary Concept)
- dicyclomine, doxylamine, pyridoxine drug combination (Supplementary Concept)
- carbinoxamine (Supplementary Concept)
- chloropyramine (Supplementary Concept)
- phenindamine (Supplementary Concept)
- emedastine (Supplementary Concept)
- alcaftadine (Supplementary Concept)
- dexbrompheniramine (Supplementary Concept)
- oxatomide (Supplementary Concept)
- picumast (Supplementary Concept)
- ebastine (Supplementary Concept)
- carebastine (Supplementary Concept)
- protopine (Supplementary Concept)
- temelastine (Supplementary Concept)
- chlorpheniramine, ephedrine drug combination (Supplementary Concept)
- 5,6-dihydrospiro(11H-imidazo(2,1-b)(3)benzazepine-11,4'-piperidine)-3-carboxamide (Supplementary Concept)
- tranilast (Supplementary Concept)
- azelastine (Supplementary Concept)
- mizolastine (Supplementary Concept)
- levocetirizine (Supplementary Concept)
- acrivastine (Supplementary Concept)
- fexofenadine (Supplementary Concept)
- levocabastine (Supplementary Concept)
- ranitidine bismuth citrate (Supplementary Concept)
- ebrotidine (Supplementary Concept)
- lafutidine (Supplementary Concept)
- etintidine (Supplementary Concept)
- mifentidine (Supplementary Concept)
- roxatidine acetate (Supplementary Concept)
- SK and F 93479 (Supplementary Concept)
- loxtidine (Supplementary Concept)
- tiotidine (Supplementary Concept)
- zolantidine (Supplementary Concept)
- TZU 0460 (Supplementary Concept)
- oxmetidine (Supplementary Concept)
- 3-(1'-cyclobutylspiro(4H-1,3-benzodioxine-2,4'-piperidine)-6-yl)-5,5-dimethyl-1,4-dihydropyridazin-6-one (Supplementary Concept)
- clobenpropit (Supplementary Concept)
- iodophenpropit (Supplementary Concept)
- thioperamide (Supplementary Concept)
- N-(2-(4-(3-(4-(cyclopropylcarbonyl)phenoxy)propyl)-1-piperazinyl)-1-methyl-2-oxoethyl)-2-furamide (Supplementary Concept)
- ciproxifan (Supplementary Concept)
- histamine H3R antagonist 2-18 (Supplementary Concept)
- 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one (Supplementary Concept)
- cyclo((2-naphthyl)alanyl-tryptophyl-(4-fluoro)phenylalanyl-threonyl-phenylalanyl-prolyl) (Supplementary Concept)
- LY 306740 (Supplementary Concept)
- MEN 10930 (Supplementary Concept)
- MDL 108,207DA (Supplementary Concept)
- YM 35375 (Supplementary Concept)
- substance P, Arg(1)-Pro(2)-Phe(7)-His(9)- (Supplementary Concept)
- CI 1021 (Supplementary Concept)
- SDZ NKT 343 (Supplementary Concept)
- HSP 117 (Supplementary Concept)
- R116301 (Supplementary Concept)
- MDL 103392 (Supplementary Concept)
- 2-(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluoro)phenyl-4-(5-(2-phosphoryl-3-oxo-4H,-1,2,4-triazolo))methylmorpholine, bis(N-methylglucamine) salt (Supplementary Concept)
- casopitant (Supplementary Concept)
- N-((2-cyclopropoxy-5-(5-trifluomethyl)tetrazol-1-yl)benzyl)-2-phenylpiperidin-3-amine (Supplementary Concept)
- 3-(6-methoxy-1-methyl-1-trifluoromethylisochroman-7-yl)methylamino-2-phenylpiperidine (Supplementary Concept)
- 6-diphenylmethyl-5-(5-isopropyl-2-methoxybenzylamino)-1-azabicyclo(2.2.2)octane-3-carboxylic acid (Supplementary Concept)
- serlopitant (Supplementary Concept)
- tyrosyl-cyclo(penicillamine-glycyl-phenylalanyl-penicillamine)-prolyl-leucyl-tryptophyl-NH-(3',5'-(CF3)2-Bzl) (Supplementary Concept)
- 2-piperazin-1-ylindan-2-carboxylic acid (3-chloro-5-fluorobenzyl)methylamide (Supplementary Concept)
- AZD 8081 (Supplementary Concept)
- AZD 2738 (Supplementary Concept)
- 1-(amino(oxo)acetyl)-N-(1-(3,5-bis(trifluoromethyl)phenyl)ethyl)-3-(4-fluoro-2-methylphenyl)-N-methylpiperidine-4-carboxamide (Supplementary Concept)
- rolapitant (Supplementary Concept)
- fosaprepitant (Supplementary Concept)
- FK886 (Supplementary Concept)
- 1-(N-(2-methoxybenzyl)acetylamino)-3-(1H-indol-3-yl)-2-(N-(2-(4-(piperidin-1-yl)piperidin-1-yl)acetyl)amino)propane (Supplementary Concept)
- (2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine (Supplementary Concept)
- S 16474 (Supplementary Concept)
- MDL 105212A (Supplementary Concept)
- quinoline-4-carboxylic acid (1-(3,5-bis-trifluoromethylbenzoyl)-2-(4-chlorobenzyl)piperidin-4-yl)amide (Supplementary Concept)
- 3-aryl-6-phenyl-1-oxa-7-azaspiro(4.5)decane (Supplementary Concept)
- 1-oxo-7-azaspirodecane (Supplementary Concept)
- PD 174424 (Supplementary Concept)
- 6-phenyl-1-oxa-7-azaspiro(4,5)decane (Supplementary Concept)
- vestipitant (Supplementary Concept)
- Sch 425078 (Supplementary Concept)
- (2-fluoromethoxy-5-(5-trifluoromethyltetrazol-1-yl)benzyl)(2-phenylpiperidin-3-yl)amine (Supplementary Concept)
- tyrosyl-alanyl-glycyl-phenylalanyl-methionyl-prolyl-leucyl-tryptophyl-O-3,5-benzyl(CF3)2 (Supplementary Concept)
- tyrosyl-alanyl-glycyl-phenylalanyl-norleucyl-prolyl-leucyl-tryptophyl-O-3,5-benzyl(CF3)2 (Supplementary Concept)
- S 18523 (Supplementary Concept)
- vofopitant (Supplementary Concept)
- CAM 4515 (Supplementary Concept)
- CAM 4750 (Supplementary Concept)
- 3-((3,5-bis(trifluoromethyl)phenyl)methyloxy)-2-phenylpiperidine (Supplementary Concept)
- L 741671 (Supplementary Concept)
- L 743310 (Supplementary Concept)
- ASN 1377642 (Supplementary Concept)
- 3-(2-methoxy-5-trifluoromethoxybenzyl)amino-1-methyl-2-phenylpiperidine (Supplementary Concept)
- N-(3,5-bis(trifluoromethyl)benzyl)-7,8-dihydro-N,7-dimethyl-5-(4-methylphenyl)-8-oxo-1,7-naphthyridine-6-carboxamide (Supplementary Concept)
- N-(1-(3,5-bis(trifluoromethyl)phenyl)ethyl)-7,8-dihydro-N,7-dimethyl-5-(4-methylphenyl)-8-oxo-1,7-naphthyridine-6-carboxamide (Supplementary Concept)
- 1-(4-(3,5-bis(trifluoromethyl)benzyloxymethyl)-4-phenylpiperidin-1-yl)-2-pyrrolidineacetamide (Supplementary Concept)
- 4-(3,5-bis(trifluoromethyl)benzyloxymethyl)-1-(2-methylthiazol-5-ylmethyl)-4-phenylpiperidine (Supplementary Concept)
- minaxolone (Supplementary Concept)
- hydroxydione (Supplementary Concept)
- alphaxalone (Supplementary Concept)
- alphadolone (Supplementary Concept)
- O(3alpha)-,O(21)-di-(N(1)-methyloxycarbonyl-2, 4-dioxo-5-fluoropyrimidinyl)-17alpha-hydroxy-5beta-pregnan-20-one (Supplementary Concept)
- 20-oxo-5-pregnan-3-yl-glutamyl 1-ester (Supplementary Concept)
- tetrahydrodeoxycorticosterone (Supplementary Concept)
- histidyl-proline diketopiperazine (Supplementary Concept)
- sipatrigine (Supplementary Concept)
- pyrrolidine-2,4-dicarboxylic acid (Supplementary Concept)
- nefazodone (Supplementary Concept)
- ammuxetine (Supplementary Concept)
- femoxetine (Supplementary Concept)
- indalpine (Supplementary Concept)
- alaproclate (Supplementary Concept)
- dual orexin receptor antagonist 12 (Supplementary Concept)
- lemborexant (Supplementary Concept)
- suvorexant (Supplementary Concept)
- DORA-22 (Supplementary Concept)
- 2-methylthio-ATP (Supplementary Concept)
- 2-hexyloxyadenosine (Supplementary Concept)
- 2-(2-phenylethoxy)adenosine (Supplementary Concept)
- binodenoson (Supplementary Concept)
- 2-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide (Supplementary Concept)
- N6-(4-(((4-((((2-((((isothiocyanatophenyl)amino)thiocarbonyl)amino)ethyl)amino)carbonyl)methyl)anilino)carbonyl)methyl)phenyl)adenosine (Supplementary Concept)
- N(6)-(4-sulfophenyl)adenosine (Supplementary Concept)
- 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)-5'-N-ethylcarboxamidoadenosine (Supplementary Concept)
- 2-((phenylisopropyl)amino)adenosine (Supplementary Concept)
- 2-((1-phenylpropyl)amino)adenosine (Supplementary Concept)
- N(6)-benzyl-5'-N-ethylcarboxamidoadenosine (Supplementary Concept)
- N(6)-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (Supplementary Concept)
- N(6)-cyclopentyladenosine (Supplementary Concept)
- N-((1S,trans)-2-hydroxycyclopentyl)adenosine (Supplementary Concept)
- ethyl 2-amino-3-benzoyl-4,7-dihydrothieno(2,3-c)pyridine-6(5H)-carboxylate (Supplementary Concept)
- RS 74513-000 (Supplementary Concept)
- CVT 2759 (Supplementary Concept)
- N-(3-iodobenzyl)-5'-O-methyladenosine (Supplementary Concept)
- 5'-O-ethyl-N-(3-iodobenzyl)adenosine (Supplementary Concept)
- VUF 5455 (Supplementary Concept)
- KMCP 98 (Supplementary Concept)
- 8-butylaminoadenosine (Supplementary Concept)
- 8-butylamino-N(6)-cyclopentyladenosine (Supplementary Concept)
- tecadenoson (Supplementary Concept)
- 8-methylamino-N6-cyclopentyladenosine (Supplementary Concept)
- 2'-deoxyribose-N6-cyclopentyladenosine (Supplementary Concept)
- 2-amino-4-benzo(1,3)dioxol-5-yl-6-(2-hydroxyethylsulfanyl)pyridine-3,5-dicarbonitrile (Supplementary Concept)
- 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine (Supplementary Concept)
- aminopyridine-3,5-dicarbonitrile (Supplementary Concept)
- regadenoson (Supplementary Concept)
- PSB-0777 (Supplementary Concept)
- BAY 60-6583 (Supplementary Concept)
- 2-(3''-(6''-bromoindolyl)ethyloxy)adenosine (Supplementary Concept)
- GW 328267 (Supplementary Concept)
- 2-amino-4-(4-hydroxyphenyl)-6-(1H-imidazol-2-ylmethylsulfanyl)pyridine-3,5-dicarbonitrile (Supplementary Concept)
- 2-chloro-N(6)-methyladenosine-5'-methyluronamide (Supplementary Concept)
- 2-chloro-N(6)-(3-iodobenzyl)-5'-N-methylcarbamoyl-4'-thioadenosine (Supplementary Concept)
- ABEA-X-BY630 (Supplementary Concept)
- CF 502 (Supplementary Concept)
- N6-methoxy-2-(4-acetylphenyl)ethynyl-5'-N-methylcarboxamidoadenosine (Supplementary Concept)
- 4'-(2-chloro-6-(3-iodobenzylamino)purine)-2',3'-O-dihydroxy-bicyclo(3.1.0)hexane (Supplementary Concept)
- MRS 2219 (Supplementary Concept)
- iso-iantheran A (Supplementary Concept)
- iso-iantheran B (Supplementary Concept)
- 8-carboxy-iso-iantheran A (Supplementary Concept)
- 3-phenacyluridine diphosphate (Supplementary Concept)
- 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate (Supplementary Concept)
- INS 48823 (Supplementary Concept)
- NF 279 (Supplementary Concept)
- MRS 1097 (Supplementary Concept)
- alpha-((4-amino-1-phenylpyrazolo(3,4-d)pyrimidin-6-yl)thio)hexanamide (Supplementary Concept)
- alpha-((4-(methylamino)-1-phenylpyrazolo(3,4-d)pyrimidin-6-yl)thio)hexanamide (Supplementary Concept)
- KF 20274 (Supplementary Concept)
- 3,6-dichloro-2'-isopropyloxy-4'-methylflavone (Supplementary Concept)
- 1,3-dipropyl-8-(4-sulfophenyl)xanthine (Supplementary Concept)
- 8-cyclopentyl-1,3-dimethylxanthine (Supplementary Concept)
- 2,4-diethyl-1-methyl-3-(ethylsulfanylcarbonyl)-5-ethyloxycarbonyl-6-phenylpyridinium (Supplementary Concept)
- MRE 3008-F20 (Supplementary Concept)
- MRS 1204 (Supplementary Concept)
- MRS 1595 (Supplementary Concept)
- 8-(4-sulfophenyl)theophylline (Supplementary Concept)
- (2-amino-4,5,6,7-tetrahydrobenzo(b)thiophen-3-yl)(4-chloronaphthalen-1-yl)methanone (Supplementary Concept)
- (2-amino-4,5,6,7-tetrahydrobenzo(b)thiophen-3-yl)(4-iodonaphthalen-1-yl)methanone (Supplementary Concept)
- KFM 19 (Supplementary Concept)
- WRC 0571 (Supplementary Concept)
- MRS 1740 (Supplementary Concept)
- MRS 1741 (Supplementary Concept)
- 2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate (Supplementary Concept)
- 8-cyclopentyl-3-(3-(4-fluorosulfonylbenzamido)propyl)-1-propylxanthine (Supplementary Concept)
- VUF 5472 (Supplementary Concept)
- 5-(((4-fluorosulfonylphenyl)amino)carbonyl)amino-8-n-propyl-2-(2-furyl)pyrazolol(4,3-e)1,2,4-triazolo(1,5-c)pyrimidine (Supplementary Concept)
- 1-benzyl-3-propyl-1H,3H-pyrido(2,1-f)purine-2,4-dione (Supplementary Concept)
- 5-(((4-pyridyl)amino)carbonyl)amino-8-methyl-2-(2-furyl)pyrazolo(4,3-e)1,2,4-triazolo(1,5-c)pyrimdiine (Supplementary Concept)
- 1-((7-methyl-2-phenylimidazo(1,2-a)(1,3,5)triazin-4-yl)amino)acetone (Supplementary Concept)
- 8-cyclopenta-3-(3-fluoropropyl)-1-propylxanthine (Supplementary Concept)
- KF 17387 (Supplementary Concept)
- 8-cyclohexylcaffeine (Supplementary Concept)
- 8-dipropyl-8-cyclopentylxanthine (Supplementary Concept)
- FSPTP pyrimidine (Supplementary Concept)
- N-(3-(2-pyridinyl)isoquinolin-1-yl)benzamidine (Supplementary Concept)
- VUF 8504 (Supplementary Concept)
- propyl 1-ethyl-8-oxo-3-phenyl-5,6,7,8-tetrahydro-7-thiaisoquinoline-4-carboxylate (Supplementary Concept)
- 4-amino-6-benzylamino-1,2-dihydro-2-phenyl-1,2,4-triazolo(4,3-a)-quinoxalin-1-one (Supplementary Concept)
- 3-(2-(4-aminophenyl)ethyl)-8-benzyl-7-(2-ethyl(2-hydroxyethyl)aminoethyl)-1-propyl-3,7-dihydropurine-2,6-dione (Supplementary Concept)
- methyl 1-(2-chloro-2-phenylethyl)-4-((2-(4-methoxyphenyl)ethyl)amino)-1H-pyrazolo(3,4-b)pyridine-5-carboxylate (Supplementary Concept)
- isopropyl 1-(2-chloro-2-phenylethyl)-4-((2-(4-methoxyphenyl)ethyl)amino)-1H-pyrazolo(3,4-b)pyridine-5-carboxylate (Supplementary Concept)
- 8-cyclopentyl-2,6-diphenylpurine (Supplementary Concept)
- 5-(5-amino-3-(4-fluorophenyl)pyrazin-2-yl)-1-isopropylprydine-2(1H)-one (Supplementary Concept)
- 5-N-methylimino-2-(3-methylphenyl)-3-phenyl-2H-(1,2,4)-thiadiazole (Supplementary Concept)
- 1-propyl-8-(4-((4-nitrophenoxy)sulfonyl)phenyl)xanthine (Supplementary Concept)
- 1-butyl-8-(4-((4-nitrophenoxy)sulfonyl)phenyl)xanthine (Supplementary Concept)
- 1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine (Supplementary Concept)
- 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine (Supplementary Concept)
- 1,3-dipropyl-8-cyclopentylxanthine (Supplementary Concept)
- 1-butyl-3-(3-hydroxypropyl)-8-(3-noradamantyl)xanthine (Supplementary Concept)
- 9-butyl-2-(3-noradamantyl)-4,5-dihydro-6H,8H-pyrimido(1,2,3-cd)purine-8,10-dione (Supplementary Concept)
- 7,8-dihydro-8-ethyl-2-(4-bicyclo(2.2.2)octan-1-ol)-4-propyl-1H-imidazo(2,1-i)purin-5(4H)-one (Supplementary Concept)
- 7-chloro-4-hydroxy-2-phenyl-1,8-naphthyridine (Supplementary Concept)
- 3,4',5-tri(glucose-3-O-succinyl)resveratrol (Supplementary Concept)
- 8-cyclopentyl-3-(3-iodoprop-2-en-1-yl)-1-propylxanthine (Supplementary Concept)
- N-(4,6-diphenylpyrimidin-2-yl)butyramide (Supplementary Concept)
- 2-(1-methyl-4-piperidinyl)-6-(2-phenylpyrazolo(1,5-a)pyridin-3-yl)-3(2H)-pyridazinone (Supplementary Concept)
- 2-amino-4-(3-trifluoromethylphenyl)-6-(2-hydroxyethylsulfanyl)pyridine-3,5-dicarbonitrile (Supplementary Concept)
- enprofylline (Supplementary Concept)
- istradefylline (Supplementary Concept)
- 3-(3-hydroxypropyl)-8-(3-methoxystyryl)-7-methyl-1-propargylxanthine (Supplementary Concept)
- 2-n-butyl-9-methyl-8-(1,2,3)triazol-2-yl-9H-purin-6-ylamine (Supplementary Concept)
- 6-methyl-7-(1,2,3)triazol-2-yl-1,6-dihydrobenzo(1,2-d-3,4-d')diimidazole (Supplementary Concept)
- 5-oxazol-2-yl-1H-pyrazolo(4,3-b)pyridin-3-ylamine (Supplementary Concept)
- 5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine (Supplementary Concept)
- 8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-1,3-dimethylxanthine (Supplementary Concept)
- SCH 442416 (Supplementary Concept)
- 3,7-dimethyl-1-propargylxanthine (Supplementary Concept)
- (7-(2-(4-difluorophenyl)-1-piperazinyl)ethyl)-2-(2-furanyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-5-amine (Supplementary Concept)
- 8-(4-(4-benzylpiperazide-1-sulfonyl)phenyl)-1-propylxanthine (Supplementary Concept)
- 1-propyl-8-(4-sulfophenyl)xanthine (Supplementary Concept)
- 4'-(2-furyl)-N-pyridin-3-yl-4,5'-bipyrimidin-2'-amine (Supplementary Concept)
- 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine (Supplementary Concept)
- N-(2-(2-phenyl-6-(4-(3-phenylpropyl)piperazine-1-carbonyl)-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)ethyl)acetamide (Supplementary Concept)
- N-(4-acetylphenyl)-2-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy)acetamide (Supplementary Concept)
- 9-chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline (Supplementary Concept)
- 1-benzyl-7-methyl-3-propyl-1H,8H-imidazo(2,1-f)purine-2,4-dione (Supplementary Concept)
- 2-(4-methoxyphenyl)-1,2,4-triazolo(1,5-a)quinoxalin-4-one (Supplementary Concept)
- 4-diphenylacetylamino-2-phenylpyrazoloquinoline (Supplementary Concept)
- 4-dibenzoylamino-2-(4-methoxyphenyl)pyrazoloquinoline (Supplementary Concept)
- 9-chloro-5-(4-methoxybenzoyl)amino-2-phenyl(1,2,3)triazolo(1,2-a)(1,2,4)benzotriazin-1-one (Supplementary Concept)
- 4-benzoylamino-2-(4-methoxyphenyl)pyrido(2,3-e)-1,2,4-triazolo(4,3-a)pyrazin-1-one (Supplementary Concept)
- SB 204070A (Supplementary Concept)
- N-(2-(phenyl)-8-methylpyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-5-yl)phenylacetamide (Supplementary Concept)
- 2-(4-nitrophenyl)-1,2,4,5-tetrahydro-1,2,4-triazolo(4,3-a)quinoxaline-1,4-dione (Supplementary Concept)
- LJ-2698 (Supplementary Concept)
- MRS 2220 (Supplementary Concept)
- AR C109318XX (Supplementary Concept)
- 8,8',8'',8'''-(carbonylbis(imino-5,13-benzenetriyl-bis(carbonylimino)))tetrakisnaphthalene-1,3,5-trisulfonic acid (Supplementary Concept)
- 2-(2-(6-methylaminopurin-9-yl)ethyl)propane-1,3-bisoxy(diammonium phosphate) (Supplementary Concept)
- pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) (Supplementary Concept)
- INS 50589 (Supplementary Concept)
- (6-(6-(3-ethylureido)-9H-purin-9-yl)-2-styryltetrahydrofuro(3,4-d)(1,3)dioxol-4-yl)methyl dihydrogen phosphate (Supplementary Concept)
- 4-((4-(1-(ethoxycarbonyl)-1-methylethoxy)-7-methyl-2-quinolyl)carbamoyl)-5-(4-(ethoxycarbonyl)piperazin-1-yl)-5-oxopentanoic acid (Supplementary Concept)
- N-(adamantan-1-ylmethyl)-5-((3-aminopyrrolidin-1-yl)methyl)-2-chlorobenzamide (Supplementary Concept)
- 1-(N,O-bis(isoquinolinesulfonyl)-N-methyltyrosyl)-4-(4-fluorophenyl)piperazine (Supplementary Concept)
- 4-(2-iodo-6-methylaminopurin-9-yl)-1-((phosphato)methyl)-2-(phosphato)bicyclo(3.1.0)hexane (Supplementary Concept)
- uridine-5'-O-(3-thiotriphosphate) (Supplementary Concept)
- 2,2'-pyridylisatogen tosylate (Supplementary Concept)
- NP-1815-PX (Supplementary Concept)
- JNJ-55308942 (Supplementary Concept)
- AZ 11645373 (Supplementary Concept)
- N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate (Supplementary Concept)
- ARC 118925XX (Supplementary Concept)
- clopidogrel carboxylic acid (Supplementary Concept)
- cangrelor (Supplementary Concept)
- FG 5893 (Supplementary Concept)
- RP5063 (Supplementary Concept)
- 4-iodo-2,5-dimethoxyphenylisopropylamine (Supplementary Concept)
- 1-(3-trifluoromethylphenyl)piperazine (Supplementary Concept)
- binospirone mesylate (Supplementary Concept)
- eltoprazine (Supplementary Concept)
- 2,5-dimethoxy-4-bromoamphetamine (Supplementary Concept)
- 3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one (Supplementary Concept)
- 5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole (Supplementary Concept)
- frovatriptan (Supplementary Concept)
- 4-fluoro-N-(3-(1-methyl-4-piperidinyl)-1H-indol-5-yl)benzamide (Supplementary Concept)
- LY 302148 (Supplementary Concept)
- LY 306258 (Supplementary Concept)
- CP 2289 (Supplementary Concept)
- 6-(4-methyl-1-piperazinyl)-7,8,9,10-tetrahydrophenanthridine (Supplementary Concept)
- 6-(4-methyl-1-piperazinyl)--7,8,9,10-tetrahydro-8,10-ethanophenanthridine (Supplementary Concept)
- CGS 12066B (Supplementary Concept)
- indorenate (Supplementary Concept)
- gepirone (Supplementary Concept)
- alpha-methylserotonin (Supplementary Concept)
- L 772405 (Supplementary Concept)
- almotriptan (Supplementary Concept)
- tandospirone (Supplementary Concept)
- flesinoxan (Supplementary Concept)
- ipsapirone (Supplementary Concept)
- LY 165163 (Supplementary Concept)
- lasmiditan (Supplementary Concept)
- mosapride (Supplementary Concept)
- 6-chloro-2-(1-piperazinyl)pyrazine (Supplementary Concept)
- 1-(3-chlorophenyl)piperazine (Supplementary Concept)
- rizatriptan (Supplementary Concept)
- phenyl biguanide (Supplementary Concept)
- 5-carboxamidotryptamine (Supplementary Concept)
- N-(3-(2-dimethylaminoethyl)-2-methyl-1H-indol-5-yl)-4-fluorobenzamide (Supplementary Concept)
- 3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide (Supplementary Concept)
- 4-(4-(3-methoxyphenyl)cyclohexyl)-1-(2-pyridinyl)piperazine (Supplementary Concept)
- N-(4-(3-methoxyphenyl)cyclohexyl)-2-(2-pyridyloxy)ethylamine (Supplementary Concept)
- tegaserod (Supplementary Concept)
- SDZ 219-964 (Supplementary Concept)
- RS 67532 (Supplementary Concept)
- 4-(2-methylthiophenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide (Supplementary Concept)
- dimethoxy-4-indophenyl-2-aminopropane (Supplementary Concept)
- eletriptan (Supplementary Concept)
- (3,4-dichlorophenyl)(4-((6-oxazol-5-ylpyridin-2-ylmethylamino)methyl)piperidin-1-yl)methanone (Supplementary Concept)
- (3,4-dichlorophenyl)(4-((6-azetidinopyridin-2-ylmethylamino)methyl)piperidin-1-yl)methanone (Supplementary Concept)
- 3-(3-(N-benzylaminomethyl)pyrrolidinyl)-5-((2-oxooxazolidin-4-yl)methyl)indole (Supplementary Concept)
- 3-(3-(N-(alpha-methylbenzyl)aminomethyl)pyrrolidiny)-5-((2-oxooxazolidinyl)methyl)indole (Supplementary Concept)
- 1-(3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl)-4-(2-(3-fluorophenyl)ethyl)piperazine (Supplementary Concept)
- N-methyl-5-tert-butyltryptamine (Supplementary Concept)
- 1-(3-chlorophenyl)biguanide (Supplementary Concept)
- zolmitriptan (Supplementary Concept)
- repinotan hydrochloride (Supplementary Concept)
- cyclohexanecarboxylic acid (2-(4-(2-bromo-5-methoxybenzyl)piperazin-1-yl)ethyl)-(2-trifluoromethoxyphenyl)amide (Supplementary Concept)
- cyclohexanecarboxylic acid, (2-methoxyphenyl)-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)amide (Supplementary Concept)
- 2-(4-(4-(7-methoxynaphthalen-1-yl)piperazin-1-yl)butyl)-4-methyl-2H-(1,2,4)triazine-3,5-dione (Supplementary Concept)
- Piclozotan (Supplementary Concept)
- 3-chloro-4-fluorophenyl-(4-fluoro-4-(((5-methylpyrimidin-2-ylmethyl)amino)methyl)piperidin-1-yl)methanone (Supplementary Concept)
- 2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5-(2H,4H)-dione (Supplementary Concept)
- 3-amino-5,6,7,8-tetrahydro-2-(4-(4-(quinolin-2-yl)piperazin-1-yl)butyl)quinazolin-4-(3H)-one (Supplementary Concept)
- befiradol (Supplementary Concept)
- 2-((4-(naphth-1-yl)piperazin-1-yl)methyl)-1,4-dioxoperhydropyrrolo(1,2-a)pyrazine (Supplementary Concept)
- 8-((3-(4-(2-methoxyphenyl)piperazin-1-yl)-2-hydroxypropyl)oxy)thiochroman (Supplementary Concept)
- naluzotan (Supplementary Concept)
- xaliproden (Supplementary Concept)
- 6-methyl-2-(4-(naphthylpiperazin-1-yl)butyl)-3-(2H)-pyridazinone (Supplementary Concept)
- naratriptan (Supplementary Concept)
- PNU 142093 (Supplementary Concept)
- N-methyl-2'-methyl-2',3'-dihydrofuro(m)aporphine (Supplementary Concept)
- 11-propargyloxy-N-methylaporphine (Supplementary Concept)
- 11-allyloxy-N-methylaporphine (Supplementary Concept)
- 1-(2-aminopropyl)-1H-indazol-6-ol (Supplementary Concept)
- 1-(3-(2-((2-ethoxy-3-pyridinyl)oxy)ethoxy)-2-pyrazinyl)-2-methylpiperazine (Supplementary Concept)
- N,N-dimethyllysergamide (Supplementary Concept)
- 4-acetoxy-dimethyltryptamine (Supplementary Concept)
- AR231630 (Supplementary Concept)
- 2-(8,9-dihydro-7H-pyrano(2,3-g)indazol-1-yl)-1-methylethylamine (Supplementary Concept)
- (2-(3-methylphenyl)cyclopropyl)methylamine (Supplementary Concept)
- C-(4,5,6-trimethoxyindan-1-yl)methanamine (Supplementary Concept)
- 9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino(2,1-a)isoindol-6(2H)-one (Supplementary Concept)
- 1-(2-aminopropyl)-1H-indazole-6-ol (Supplementary Concept)
- 1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta(b)(1,4)diazepino(6,7,1hj)indole (Supplementary Concept)
- 5-chloro-7-methyl-2-(1-homopiperazinyl)benzoxazole (Supplementary Concept)
- 1-oxo-5-hydroxytryptamine (Supplementary Concept)
- prucalopride (Supplementary Concept)
- 6,7-dihydro-4-hydroxy-7-isopropyl-6-oxo-N-(3-(piperidin-1-yl)propyl)thieno(2,3-b)pyridine-5-carboxamide (Supplementary Concept)
- CJ 033466 (Supplementary Concept)
- minesapride (Supplementary Concept)
- ATI 7505 (Supplementary Concept)
- YH12852 (Supplementary Concept)
- MP3950 (Supplementary Concept)
- 1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate (Supplementary Concept)
- clovoxamine (Supplementary Concept)
- azasetron (Supplementary Concept)
- ramosetron (Supplementary Concept)
- altanserin (Supplementary Concept)
- 2-methoxy-4-amino-5-chlorobenzoic acid 2-(diethylamino)ethyl ester (Supplementary Concept)
- UH 301 (Supplementary Concept)
- sarpogrelate (Supplementary Concept)
- zatosetron (Supplementary Concept)
- 4-(2'-methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine (Supplementary Concept)
- N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide (Supplementary Concept)
- GR 127935 (Supplementary Concept)
- alosetron (Supplementary Concept)
- SR 46349B (Supplementary Concept)
- DuP 734 (Supplementary Concept)
- volinanserin (Supplementary Concept)
- 3,N-dimethyl-N-(1-methyl-3-(4-methylpiperidin-1-yl)propyl)benzenesulfonamide (Supplementary Concept)
- xylamidine (Supplementary Concept)
- renzapride (Supplementary Concept)
- LY 53857 (Supplementary Concept)
- bemesetron (Supplementary Concept)
- 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine (Supplementary Concept)
- 1-(2-methoxyphenyl)-4-(4--(2-phthalimido)cyclohexyl)piperazine (Supplementary Concept)
- 4-(3-(1-benzotriazolyl)cyclohexyl)-1-(2-methoxyphenyl)piperazine (Supplementary Concept)
- N-(1-azabicyclo(2.2.2)oct-3-yl)benzimidazole-4-carboxamide (Supplementary Concept)
- N-(1-azabicyclo(2.2.2)oct-3-yl)--6-chlorobenzimidazole-4-carboxamide (Supplementary Concept)
- N-(1-azabicyclo(2.2.2)oct-3-yl)-6--chloro-7-nitrobenzimidazole-4-carboxamide (Supplementary Concept)
- 2-ethyl-5-methoxy-N,N-dimethyltryptamine (Supplementary Concept)
- LY 426965 (Supplementary Concept)
- SL 88.0338 (Supplementary Concept)
- 6-nitroquipazine (Supplementary Concept)
- 5-((N-propylpiperidin-4-yl)methoxy)-1,2,3,4-tetrahydrobenzo(h)(1,6)naphthyridine (Supplementary Concept)
- N-(5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl)-4-morpholinobenzamide (Supplementary Concept)
- 2-(4-((6-amino-1,3-dioxo-1H-benzo(de)isoquinolin-2(3H)-yl)methyl)piperidin-1-yl)ethyl 4-amino-5-chloro-2-methoxybenzoate (Supplementary Concept)
- 3-(benzenesulfonyl)-2-(methylsulfanyl)pyrido(1,2-a)pyrimidin-4-ylidenamine (Supplementary Concept)
- cianopramine (Supplementary Concept)
- zacopride (Supplementary Concept)
- pipamperone (Supplementary Concept)
- setoperone (Supplementary Concept)
- (2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine (Supplementary Concept)
- deramciclane (Supplementary Concept)
- AVN-492 (Supplementary Concept)
- WAY 100135 (Supplementary Concept)
- GR 113808 (Supplementary Concept)
- dotarizine (Supplementary Concept)
- SB 206553 (Supplementary Concept)
- LY 367265 (Supplementary Concept)
- REC 15-3079 (Supplementary Concept)
- 4-((1-(2-(2,4-difluorophenyl)ethyl)-4-piperidinyl)sulfonyl)benzonitrile (Supplementary Concept)
- 4-((1-(2-(2,4-difluorophenyl)ethyl)-4-piperidinyl)sulfonyl)benzamide (Supplementary Concept)
- 1-(4-fluorophenyl)-2-(4-(phenylsulfonyl)-1-piperidinyl)ethanone (Supplementary Concept)
- LY 393558 (Supplementary Concept)
- 2-((2-(dimethylamino)ethyl)thio)-3-phenylquinoline (Supplementary Concept)
- McN 5652 (Supplementary Concept)
- 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine (Supplementary Concept)
- tolfenamic acid (Supplementary Concept)
- iprazochrome (Supplementary Concept)
- amperozide (Supplementary Concept)
- butanserin (Supplementary Concept)
- 3-(3-(dimethylamino)propyl)-4-hydroxy-N-(4-(4-pyridinyl)phenyl)benzamide (Supplementary Concept)
- 8-(5-(5-amino-2,4-dimethoxyphenyl)-5-oxopentyl)-1,3,8-triazaspiro(4.5)decane-2,4-dione (Supplementary Concept)
- 2a-(4-phenyl-1,2,3,6-tetrahydropyridyl)cyclohex(a-3,4)indole-2-one (Supplementary Concept)
- 2-(3,5-dimethylpiperidino)ethyl 4-amino-5-chloro-2-methoxybenzoate (Supplementary Concept)
- 5-(4-fluorophenyl)-3-(2-hydroxy-3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)-5-methylhydantoin (Supplementary Concept)
- BRL 15572 (Supplementary Concept)
- MM 77 (Supplementary Concept)
- N-(8'-hydroxy-2'-methyl-5'-(2-methylpropyl)-3',6'-dioxo-7'-(phenylmethyl)oxazolidino(2,3-c)piperazin-2'-yl) 6-methylergoline-8-carboxamide (Supplementary Concept)
- 5-fluoro-8-(4-(4-(6-methoxyquinolin-8-yl)piperazin-1-yl)piperidin-1-yl)quinoline (Supplementary Concept)
- isamoltane (Supplementary Concept)
- 3-(cyclobutyl(3-(5-fluoro-1H-indol-3-yl)propyl)amino)-8-fluorochromane-5-carboxamide (Supplementary Concept)
- 1-(4-(2-methoxyisopropyl)phenyl)-3-(2-(4-methylpiperazin-1-yl)benzyl)pyrrolidin-2-one (Supplementary Concept)
- pimavanserin (Supplementary Concept)
- AR 246686 (Supplementary Concept)
- APD791 (Supplementary Concept)
- 5-(((4-benzo(a)isothiazol-3-yl)piperazin-1-yl)methyl)-6-chloroindolin-2-one (Supplementary Concept)
- 2-(4-methoxyphenyl)-N-(4-methylbenzyl)-N-(1-methylpiperidin-4-yl)acetamide (Supplementary Concept)
- itasetron (Supplementary Concept)
- dolasetron (Supplementary Concept)
- 3-(4-methoxybenzyl)-N-(3-(2-piperidin-1-yl)ethyl)-2,4-dioxoquinazoline-7-carboxamide (Supplementary Concept)
- 2-(4-allylpiperazin-1-yl)-1,8-naphthyridine-3-carbonitrile (Supplementary Concept)
- hexahydro-1H-pyrrolizin-1-ylmethyl 1-methyl-1H-indole-3-carboxylate (Supplementary Concept)
- Prenylamine (MeSH Term)
- Debrisoquin (MeSH Term)
- Benzphetamine (MeSH Term)
- Bethanidine (MeSH Term)
- Guanethidine (MeSH Term)
- Amphetamine (MeSH Term)
- Ephedrine (MeSH Term)
- Methamphetamine (MeSH Term)
- Phentermine (MeSH Term)
- Oxidopamine (MeSH Term)
- Naphazoline (MeSH Term)
- Norepinephrine (MeSH Term)
- Octopamine (MeSH Term)
- Oxymetazoline (MeSH Term)
- Synephrine (MeSH Term)
- Epinephrine (MeSH Term)
- Etilefrine (MeSH Term)
- Racepinephrine (MeSH Term)
- Phenylpropanolamine (MeSH Term)
- Mephentermine (MeSH Term)
- Midodrine (MeSH Term)
- Ergotamine (MeSH Term)
- Metaraminol (MeSH Term)
- Methoxamine (MeSH Term)
- Phenylephrine (MeSH Term)
- Guanfacine (MeSH Term)
- Brimonidine Tartrate (MeSH Term)
- Brimonidine Tartrate, Timolol Maleate Drug Combination (MeSH Term)
- Clonidine (MeSH Term)
- Guanabenz (MeSH Term)
- Methyldopa (MeSH Term)
- Xylazine (MeSH Term)
- Medetomidine (MeSH Term)
- Dexmedetomidine (MeSH Term)
- Rilmenidine (MeSH Term)
- Tretoquinol (MeSH Term)
- Isoproterenol (MeSH Term)
- Isoxsuprine (MeSH Term)
- Nylidrin (MeSH Term)
- Oxyfedrine (MeSH Term)
- Clenbuterol (MeSH Term)
- Nebivolol (MeSH Term)
- Prenalterol (MeSH Term)
- Xamoterol (MeSH Term)
- Dobutamine (MeSH Term)
- Terbutaline (MeSH Term)
- Salmeterol Xinafoate (MeSH Term)
- Formoterol Fumarate (MeSH Term)
- Isoetharine (MeSH Term)
- Metaproterenol (MeSH Term)
- Procaterol (MeSH Term)
- Fenoterol (MeSH Term)
- Albuterol (MeSH Term)
- Ritodrine (MeSH Term)
- Hexoprenaline (MeSH Term)
- Bretylium Tosylate (MeSH Term)
- Dihydroergocristine (MeSH Term)
- Moxisylyte (MeSH Term)
- Tolazoline (MeSH Term)
- Dibenzylchlorethamine (MeSH Term)
- Dihydroergotoxine (MeSH Term)
- Nicergoline (MeSH Term)
- Mianserin (MeSH Term)
- Quinidine (MeSH Term)
- Ergoloid Mesylates (MeSH Term)
- Phenoxybenzamine (MeSH Term)
- Phentolamine (MeSH Term)
- Piperoxan (MeSH Term)
- Labetalol (MeSH Term)
- Prazosin (MeSH Term)
- Doxazosin (MeSH Term)
- Carvedilol (MeSH Term)
- Indoramin (MeSH Term)
- Tamsulosin (MeSH Term)
- Lurasidone Hydrochloride (MeSH Term)
- Idazoxan (MeSH Term)
- Yohimbine (MeSH Term)
- Mirtazapine (MeSH Term)
- Levobunolol (MeSH Term)
- Bupranolol (MeSH Term)
- Penbutolol (MeSH Term)
- Timolol (MeSH Term)
- Propranolol (MeSH Term)
- Dihydroalprenolol (MeSH Term)
- Nadolol (MeSH Term)
- Oxprenolol (MeSH Term)
- Iodocyanopindolol (MeSH Term)
- Alprenolol (MeSH Term)
- Carteolol (MeSH Term)
- Sotalol (MeSH Term)
- Metipranolol (MeSH Term)
- Bunolol (MeSH Term)
- Pindolol (MeSH Term)
- Betaxolol (MeSH Term)
- Acebutolol (MeSH Term)
- Practolol (MeSH Term)
- Celiprolol (MeSH Term)
- Bisoprolol (MeSH Term)
- Atenolol (MeSH Term)
- Metoprolol (MeSH Term)
- Butoxamine (MeSH Term)
- Tetrabenazine (MeSH Term)
- Atomoxetine Hydrochloride (MeSH Term)
- Maprotiline (MeSH Term)
- Mazindol (MeSH Term)
- Protriptyline (MeSH Term)
- Desipramine (MeSH Term)
- Nortriptyline (MeSH Term)
- Opipramol (MeSH Term)
- N-Methyl-3,4-methylenedioxyamphetamine (MeSH Term)
- Amitriptyline (MeSH Term)
- Amoxapine (MeSH Term)
- Reserpine (MeSH Term)
- Dothiepin (MeSH Term)
- Imipramine (MeSH Term)
- Trimipramine (MeSH Term)
- Tyramine (MeSH Term)
- Viloxazine (MeSH Term)
- 3,4-Methylenedioxyamphetamine (MeSH Term)
- Tapentadol (MeSH Term)
- Reboxetine (MeSH Term)
- Dronabinol (MeSH Term)
- Rimonabant (MeSH Term)
- Hemicholinium 3 (MeSH Term)
- Holothurin (MeSH Term)
- Botulinum Toxins (MeSH Term)
- Botulinum Toxins, Type A (MeSH Term)
- Arecoline (MeSH Term)
- Carbachol (MeSH Term)
- Acetylcholine (MeSH Term)
- Methacholine Chloride (MeSH Term)
- (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride (MeSH Term)
- Muscarine (MeSH Term)
- Oxotremorine (MeSH Term)
- Bethanechol (MeSH Term)
- Pilocarpine (MeSH Term)
- Varenicline (MeSH Term)
- Lobeline (MeSH Term)
- Nicotine (MeSH Term)
- Dimethylphenylpiperazinium Iodide (MeSH Term)
- Tiotropium Bromide (MeSH Term)
- Meclizine (MeSH Term)
- Ipratropium (MeSH Term)
- Scopolamine (MeSH Term)
- Butylscopolammonium Bromide (MeSH Term)
- Tolterodine Tartrate (MeSH Term)
- Solifenacin Succinate (MeSH Term)
- Procyclidine (MeSH Term)
- Propantheline (MeSH Term)
- Propylbenzilylcholine Mustard (MeSH Term)
- Dexetimide (MeSH Term)
- Dicyclomine (MeSH Term)
- Orphenadrine (MeSH Term)
- Oxyphenonium (MeSH Term)
- Benactyzine (MeSH Term)
- Benztropine (MeSH Term)
- Biperiden (MeSH Term)
- Cyclopentolate (MeSH Term)
- Glycopyrrolate (MeSH Term)
- Atropine (MeSH Term)
- Quinuclidinyl Benzilate (MeSH Term)
- Emepronium (MeSH Term)
- Trihexyphenidyl (MeSH Term)
- Tropicamide (MeSH Term)
- Hyoscyamine (MeSH Term)
- Pirenzepine (MeSH Term)
- Methantheline (MeSH Term)
- Pancuronium (MeSH Term)
- Pempidine (MeSH Term)
- Pentolinium Tartrate (MeSH Term)
- Toxiferine (MeSH Term)
- Mecamylamine (MeSH Term)
- Pipecuronium (MeSH Term)
- Hexamethonium (MeSH Term)
- Curare (MeSH Term)
- Gallamine Triethiodide (MeSH Term)
- Alcuronium (MeSH Term)
- Atracurium (MeSH Term)
- Ethidium (MeSH Term)
- Chlorisondamine (MeSH Term)
- Trimethaphan (MeSH Term)
- Tubocurarine (MeSH Term)
- Vecuronium Bromide (MeSH Term)
- Paraoxon (MeSH Term)
- Parathion (MeSH Term)
- Tacrine (MeSH Term)
- Tetrachlorvinphos (MeSH Term)
- Tetraisopropylpyrophosphamide (MeSH Term)
- Rivastigmine (MeSH Term)
- Isoflurophate (MeSH Term)
- Malathion (MeSH Term)
- Pyridostigmine Bromide (MeSH Term)
- Diazinon (MeSH Term)
- Dichlorvos (MeSH Term)
- Naled (MeSH Term)
- Neostigmine (MeSH Term)
- Coumaphos (MeSH Term)
- Fenitrothion (MeSH Term)
- Fenthion (MeSH Term)
- Galantamine (MeSH Term)
- Aldicarb (MeSH Term)
- Ambenonium Chloride (MeSH Term)
- Propoxur (MeSH Term)
- Armin (MeSH Term)
- Azinphosmethyl (MeSH Term)
- Carbofuran (MeSH Term)
- Mevinphos (MeSH Term)
- Monocrotophos (MeSH Term)
- Sarin (MeSH Term)
- Carbaryl (MeSH Term)
- Soman (MeSH Term)
- Dimethoate (MeSH Term)
- Chlorpyrifos (MeSH Term)
- Fonofos (MeSH Term)
- Echothiophate Iodide (MeSH Term)
- Edrophonium (MeSH Term)
- Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester (MeSH Term)
- Chlorfenvinphos (MeSH Term)
- Trichlorfon (MeSH Term)
- Methomyl (MeSH Term)
- Methyl Parathion (MeSH Term)
- Phorate (MeSH Term)
- Phosphamidon (MeSH Term)
- Physostigmine (MeSH Term)
- Donepezil (MeSH Term)
- Obidoxime Chloride (MeSH Term)
- Trimedoxime (MeSH Term)
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MeSH Term)
- Duloxetine Hydrochloride (MeSH Term)
- Levodopa (MeSH Term)
- Memantine (MeSH Term)
- Benserazide (MeSH Term)
- Fusaric Acid (MeSH Term)
- Amantadine (MeSH Term)
- Carbidopa (MeSH Term)
- Dihydroxyphenylalanine (MeSH Term)
- Dopamine (MeSH Term)
- Dexpramipexole (MeSH Term)
- 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine (MeSH Term)
- Pergolide (MeSH Term)
- Aripiprazole (MeSH Term)
- Lisuride (MeSH Term)
- Dihydroergotamine (MeSH Term)
- Bromocriptine (MeSH Term)
- Fenoldopam (MeSH Term)
- Quinpirole (MeSH Term)
- Apomorphine (MeSH Term)
- Dihydroergocornine (MeSH Term)
- Dihydroergocryptine (MeSH Term)
- Metergoline (MeSH Term)
- Piribedil (MeSH Term)
- Cabergoline (MeSH Term)
- Pramipexole (MeSH Term)
- Butaclamol (MeSH Term)
- Penfluridol (MeSH Term)
- Perazine (MeSH Term)
- Perphenazine (MeSH Term)
- Thiethylperazine (MeSH Term)
- Thioridazine (MeSH Term)
- Thiothixene (MeSH Term)
- Acepromazine (MeSH Term)
- Loxapine (MeSH Term)
- Prochlorperazine (MeSH Term)
- Promazine (MeSH Term)
- Benperidol (MeSH Term)
- Remoxipride (MeSH Term)
- Risperidone (MeSH Term)
- Clopenthixol (MeSH Term)
- Raclopride (MeSH Term)
- Flupenthixol (MeSH Term)
- Fluphenazine (MeSH Term)
- Fluspirilene (MeSH Term)
- Azaperone (MeSH Term)
- Spiperone (MeSH Term)
- Sulpiride (MeSH Term)
- Domperidone (MeSH Term)
- Haloperidol (MeSH Term)
- Chlorpromazine (MeSH Term)
- Chlorprothixene (MeSH Term)
- Trifluoperazine (MeSH Term)
- Trifluperidol (MeSH Term)
- Triflupromazine (MeSH Term)
- Tiapride Hydrochloride (MeSH Term)
- Mesoridazine (MeSH Term)
- Methotrimeprazine (MeSH Term)
- Pimozide (MeSH Term)
- Amisulpride (MeSH Term)
- Paliperidone Palmitate (MeSH Term)
- Metoclopramide (MeSH Term)
- Droperidol (MeSH Term)
- Lisdexamfetamine Dimesylate (MeSH Term)
- Dextroamphetamine (MeSH Term)
- Nomifensine (MeSH Term)
- Cocaine (MeSH Term)
- Methylphenidate (MeSH Term)
- Dexmethylphenidate Hydrochloride (MeSH Term)
- Bupropion (MeSH Term)
- N-Methylaspartate (MeSH Term)
- Quisqualic Acid (MeSH Term)
- Kainic Acid (MeSH Term)
- alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (MeSH Term)
- Ibotenic Acid (MeSH Term)
- 2-Amino-5-phosphonovalerate (MeSH Term)
- Dizocilpine Maleate (MeSH Term)
- Ketamine (MeSH Term)
- Kynurenic Acid (MeSH Term)
- Dextromethorphan (MeSH Term)
- Dextrorphan (MeSH Term)
- 6-Cyano-7-nitroquinoxaline-2,3-dione (MeSH Term)
- Riluzole (MeSH Term)
- Ibogaine (MeSH Term)
- 2-Aminoadipic Acid (MeSH Term)
- Phencyclidine (MeSH Term)
- Phenobarbital (MeSH Term)
- Gabapentin (MeSH Term)
- Felbamate (MeSH Term)
- Vigabatrin (MeSH Term)
- gamma-Aminobutyric Acid (MeSH Term)
- Aminooxyacetic Acid (MeSH Term)
- Valproic Acid (MeSH Term)
- 3-Mercaptopropionic Acid (MeSH Term)
- Muscimol (MeSH Term)
- Zolpidem (MeSH Term)
- Clobazam (MeSH Term)
- Baclofen (MeSH Term)
- Pentylenetetrazole (MeSH Term)
- Clozapine (MeSH Term)
- Allylglycine (MeSH Term)
- Bicuculline (MeSH Term)
- Picrotoxin (MeSH Term)
- Pentobarbital (MeSH Term)
- Temazepam (MeSH Term)
- Thiamylal (MeSH Term)
- Thiopental (MeSH Term)
- Lorazepam (MeSH Term)
- Medazepam (MeSH Term)
- Mephobarbital (MeSH Term)
- Prazepam (MeSH Term)
- Primidone (MeSH Term)
- Nordazepam (MeSH Term)
- Diazepam (MeSH Term)
- Nitrazepam (MeSH Term)
- Oxazepam (MeSH Term)
- Bromazepam (MeSH Term)
- Clonazepam (MeSH Term)
- Clorazepate Dipotassium (MeSH Term)
- Flumazenil (MeSH Term)
- Flunitrazepam (MeSH Term)
- Flurazepam (MeSH Term)
- Alprazolam (MeSH Term)
- Amobarbital (MeSH Term)
- Barbital (MeSH Term)
- Midazolam (MeSH Term)
- Secobarbital (MeSH Term)
- Estazolam (MeSH Term)
- Hexobarbital (MeSH Term)
- Chlordiazepoxide (MeSH Term)
- Chlormethiazole (MeSH Term)
- Triazolam (MeSH Term)
- Zolazepam (MeSH Term)
- Tiagabine (MeSH Term)
- Carbon Monoxide (MeSH Term)
- Hydrogen Sulfide (MeSH Term)
- Glycine (MeSH Term)
- Strychnine (MeSH Term)
- Betahistine (MeSH Term)
- Betazole (MeSH Term)
- Dimaprit (MeSH Term)
- Impromidine (MeSH Term)
- Histamine (MeSH Term)
- Butyric Acid (MeSH Term)
- Doxepin (MeSH Term)
- Ketotifen (MeSH Term)
- Promethazine (MeSH Term)
- Pyrilamine (MeSH Term)
- Brompheniramine (MeSH Term)
- Clemastine (MeSH Term)
- Cyclizine (MeSH Term)
- Cyproheptadine (MeSH Term)
- Flunarizine (MeSH Term)
- Antazoline (MeSH Term)
- Dimenhydrinate (MeSH Term)
- Dimethindene (MeSH Term)
- Diphenhydramine (MeSH Term)
- Doxylamine (MeSH Term)
- Hydroxyzine (MeSH Term)
- Chlorpheniramine (MeSH Term)
- Cinnarizine (MeSH Term)
- Tripelennamine (MeSH Term)
- Triprolidine (MeSH Term)
- Methapyrilene (MeSH Term)
- Pheniramine (MeSH Term)
- Olopatadine Hydrochloride (MeSH Term)
- Cetirizine (MeSH Term)
- Loratadine (MeSH Term)
- Astemizole (MeSH Term)
- Terfenadine (MeSH Term)
- Burimamide (MeSH Term)
- Famotidine (MeSH Term)
- Metiamide (MeSH Term)
- Ranitidine (MeSH Term)
- Cimetidine (MeSH Term)
- Nizatidine (MeSH Term)
- Aprepitant (MeSH Term)
- Desvenlafaxine Succinate (MeSH Term)
- Venlafaxine Hydrochloride (MeSH Term)
- Milnacipran (MeSH Term)
- Levomilnacipran (MeSH Term)
- Citalopram (MeSH Term)
- Trazodone (MeSH Term)
- Vilazodone Hydrochloride (MeSH Term)
- Norfenfluramine (MeSH Term)
- Paroxetine (MeSH Term)
- Clomipramine (MeSH Term)
- Sertraline (MeSH Term)
- Fenfluramine (MeSH Term)
- Fluoxetine (MeSH Term)
- Zimeldine (MeSH Term)
- Olanzapine (MeSH Term)
- Fluvoxamine (MeSH Term)
- Vortioxetine (MeSH Term)
- Escitalopram (MeSH Term)
- Adenosine (MeSH Term)
- Caffeine (MeSH Term)
- Theophylline (MeSH Term)
- Aminophylline (MeSH Term)
- Ticlopidine (MeSH Term)
- Clopidogrel (MeSH Term)
- Ticagrelor (MeSH Term)
- p-Chloroamphetamine (MeSH Term)
- 5,6-Dihydroxytryptamine (MeSH Term)
- 5,7-Dihydroxytryptamine (MeSH Term)
- Buspirone (MeSH Term)
- Lysergic Acid Diethylamide (MeSH Term)
- 8-Hydroxy-2-(di-n-propylamino)tetralin (MeSH Term)
- Cisapride (MeSH Term)
- Dexfenfluramine (MeSH Term)
- Quipazine (MeSH Term)
- Serotonin (MeSH Term)
- N,N-Dimethyltryptamine (MeSH Term)
- DOM 2,5-Dimethoxy-4-Methylamphetamine (MeSH Term)
- Mescaline (MeSH Term)
- Sumatriptan (MeSH Term)
- Fenclonine (MeSH Term)
- Ketanserin (MeSH Term)
- Nafronyl (MeSH Term)
- Bufotenin (MeSH Term)
- Methysergide (MeSH Term)
- Cinanserin (MeSH Term)
- Methiothepin (MeSH Term)
- Pizotyline (MeSH Term)
- Ritanserin (MeSH Term)
- Ondansetron (MeSH Term)
- Granisetron (MeSH Term)
- Palonosetron (MeSH Term)
- Tropisetron (MeSH Term)